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ROBERT C. BATTERMAN
A brief glance at any pharmacological book or treatise on thera-
peutics will reveal that there are actually only a handful of-drugs
which have been advocated for the relief of pain. All of these have
been in clinical use for many years, and their usefulness in thie treat-
ment of pain in general, or for the treatment of a specific condition,
has been accepted as colmmon knowledge and medical teaching.
Unfortunately, the dinician too often prescribes an analgesic and,
without any further follow-up, assumes tha;t the patient had relief
of pain. Because this was the medication advocated for this condi-
tion, the expected response must have occurred. If the patient does
not respond in the accepted manner, he is considered to be a psycho-
neurotic with magnification of his symptoms. Of course, the drug
is never at fault. Occasionally the converse occurs, particularly
when new analgesic agents are used and an over-zealous investigator
may have primed the patient about the anticipated benefit. Although
the patient may not have noted any particular alleviation of the
pain, he feels that since the doctor is making all efforts to help him,
it would be discouraging to give a negative report. The patient,
always respectful of the physician and somewhat overwhelmed by
the unusual attention, invariably claims to be improved.
The problem is at once apparent. A study of analgesic agents
is meaningless unless one considers the symptom of pain as it is
manifested by the individual patient. We cannot, at the present,
divorce the complaint from the patient as a whole. Pain is a sub-
jective symptom. Recent work has emphasized the pain threshold
and reactivity of the patient,2' 4, particularly alterations in facial
expressions resulting from application of a known stimulus such as
intense heat or inflated balloons. These methods are very import-
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ant contributions to the subject of pain and its treatment, but do not
satisfy or replace the clinical need for careful analysis of the individ-
ual's pain symptom complex and response to therapy. There is no
question that the reactivity to a painful stimulus varies markedly
from subject to subject and even in the same individual from time to
time. Under standardized conditions this is a measurable quantity
in the hands of capable investigators and intelligent subjects. Con-
sider the difficulties, however, of evaluating the complaints of a
patient who is supposedly in distress on the basis of organic disease.
In addition to the perception of the painful stimulus, every patient
varies to an astounding degree in the development of associated ideas
or introspective ainalyses of the responsible factor for the discomfort.
One patient may noit be distressed by the severest form of pain, while
another, because of fear of sudden death, or of the possibility of a
fatal disease, reacts almost explosively both physiologically and psy-
chologically to the mildest type of pain. The fact that must be
emphasized is that we possess no means of accurately evaluating the
severity, quality, and duration of the pain except by careful history.
The patient's description of th'e symp-tom is our sole guide to its
severity, and should be accepted as such regardless of the underlying
disease or psychological make-up of the patient. The clinician, on
th'e basis of experience and appreciation of the latter factor, may
more accurately gauge the significance of the complaint, but he can-
not and should not in any way deny the presence of the pain or its
stated severity. This dilemma also holds true for evaluating the
response totherapy. The patient may appear more comfortable and
anxiety is lessened, 'but other than these questionable objective signs,
one must rely on the patient's admission of the degree of relief.
The production of sleep following the administration of the analgesic
is not a sign of relief of pain, but rather an additional action of the
drug upon the central nervous system. By definition, analgesics are
a group of drugs which relieve pain without loss of consciousness.
Although, in some patients, it may be advantageous to have sleep
produced, it is not a function of analgesia and in most instances is
undesirable.
Th'e W.Tolff, Hardy, and Goodell technique2 4' for evaluating
the effectiveness of analgesic agents by deterrmining the pain thresh-
old contributed greatly to our knowledge ofthese drugs. However,
it is well recognized and has been emphasized by Wolff and asso-
ciates themselves that the elevation of the pain threshold is only
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one of the possible modes of action of analgesics. It is probable, in
light of clinical experience, that it is of minor importance in regard
to analgesic effectiveness when such drugs are administered for the
relief of pain. Overwhelming evidence has accumulated to sub-
stantiate this interpretation. Excluding for the moment those drugs
which, in spite of a negligible or even absent effect upon the pain
threshold, exert a marked analgesic action when given for specific
conditions; for example, colchicine for gout and salicylates for rheu-
matic fever; the majority of analgesic agents exert their main action
within the central nervous system. Considering the various levels
of integration of pain which exist within the central nervous system,
the cerebral cortex, thalamus, tectum mesencephali, and perhaps the
internuncial pool of neurons within the central gray matter of the
.pinai curci, t iee aalgesic may hypothetically alter the transmission
of the pain impulse from the periphery to the cerebral cortex where
the consciousness or awareness of the pain is manifest. The cerebral
cortical level appears to be the most important. Not only is this
the highest level for normal appreciation of pain, but this perception
may be altered by other cortical centers. Thus, an individual under
excitement or emotional stress may not be aware of a painful wound.
Mental processes also affect the perception of pain.
Wolff and Goodell7have demonstrated that with suggestibility,
variability in moods, anticipation of an expected response, and other
psychic factors, the pain threshold may be raised to a level equivalent
to that achieved with mild analgesic drugs. Emphasis for the action
of analgesics is placed upon the ability of the drug to alter the reac-
tivity ofthe patientto the disturbingsymptolms. Those drugs which
possess a marked psychic effect on the individual are the most potent
as regards analgesia. Thus, it is commonly accepted that the patient
is still aware of pain but he is no longer perturbed by its presence.
In other words, the fear and associated implications are decreased
or abolished. 'This theory explains, perhaps, why morphine and
demerol continue to exert an analgesic action long after a tolerance
to the peripheral pain threshold effect occurs. It also attempts to
explain the analgesic effects of a placebo. With suggestibility, the
pain threshold may be elevated after administration of a placebo,
but this response is never great nor prolonged. In our experience,
regardless of the severity of pain or the underlying organic disease,
a placebo will result in analgesia in approximately 40 per cent of
the trials. In solme instances this response is indistinguishable from
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that achieved with the accepted potent analgesics and may be pro-
duced repeatedly. A patient may even be psychically addicted to
the placebo and demand its continued administration. It is apparent
that in evaluating analgesic drugs, they must exceed in effectiveness
the expected incidence of response to a placebo, before they can be
accepted as analgesic agents. Furthermore, the common practice of
adminfistering a placebo after a course of a potent analgesic and
because of a response classifying the patient as a psychoneurotic is
entirely unjustified. Not onlv will the patient respond to the
placebo because of the anticipation of relief, but an entirely new
mechanism becomes evident. In attempting to study the addiction
liability of demerol, a group of patients who had been treated for
pain over a period of months were given, without itheir knowledge,
a placebo according to the same dosage schedule. Much to our
amazement, the patients continued to have analgesia for periods of
24 to 96 hours, at which time the placebo gradually became less and
less effective and pain recurred to the level existing before analgesia
was achieved at the onset with demerol. Incidentally, none of these
patients presented signs and symptoms of abstinence phenomena
indicative of physical dependence. These patients were either con-
ditioned to the analgesic response so that, for variable periods there-
after this response could be elicited by other drugs, or else a potent
analgesic, after prolonged use, may alter the physiological responses
within the central nervous system so that a persistence of effect may
exist even though the drug is no longer present within the body.
That the latter is probably the most likely explanation appears from
a duplication of the above experiment, but this time without the use
of placeboes. Discontinuing entirely the administration of the
analgesic, the same results are achieved, ithe patient continuing to be
free of pain for 24 to 96 hours. That persistence of action is not
an unusual pharmacollogical response can be readily appreciated when
one considers other clinical examples such as continued relief of
intercostal pain resulting from a rib fracture by a single nerve injec-
tion of procaine. Alithough one cannot escape the impression that
the psychological component is perhaps th;e most important action
of an analgesic, it seems that the integrating levels below the cortex
should not be entirely neglected. I 'have in mind experiences in
morphine addicts which perhaps indicate a midway action. It is
well recognized that morphine addicts will develop a marked toler-
ance to the drug so that large doses are necessary to achieve a repe-
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tition of an euphoric response. It is also well known that every
effect of morphine which will produce the phenomenon of tolerance
does so with independent dosage levels. Thus, each indivi'dual has
an optimum dose level which will give a desired action. The toler-
ance to the analgesic action of morphine tapers off when 30 to 45 mg.
are reached, but there-is no apparent limit for the euphoric or psychic
response. Why is it then, that morphine addicts, if pain is present,
will respond to a dose of morphine which is relatively very small
and will not piroduce a psychic effect? Since most analgesics have
pharmacological actions upon suibcortical areas, it is conceivable that
they may exert a "blocking" effect at one of the lower integrating
levels. It has been stated7 that even after pain is relieved subjec-
tively certain patients continue to be aware of their pain. In my
experience, this is not necessarily true. The majority of patients
have compliete cessation of the pain with recurrence of the perception
when the drug is dissipated. It is, therefore, my conclusion that the
central action of analgesics is a combination of the psychic together
with some interference with the sensation reaching the consciousness.
In any individual patient, either feature may play the dominant
role, ;but both are probably coexisting.
'The next problem confronting the physician is what types of pain
occur clinically. Regardless of its severity and duration, pain can
be classified according to four major groups. The largest number
of patients present pain secondary to some inflammatory or patho-
logical process involving visceral or musculo-skeletal structures.
This includes every organ of the body and represents the type of
pain seen postoperatively, with malignancies, surgical wounds, frac-
tures, arthritis, gangrene, and pleural, pericardial, peritoneal, and
meningeal irritations as typical examples. The second largest group
ofpatients possess pain ofneurological origin and include non-specific
headaches, neuri'tis, neuralgias, and root pains. The third group of
patients present themselves with spasms of smooth muscle involving
the gastro-intestinal, genito-urinary, biliary, or circulatory systems.
Finally, there exists a group of patients who, as far as can be deter-
mined, do not possess any organic or functional explanation for their
complaints, with the result that the pain is classified as psychalgia.
This, of course, is the hardest diagnosis to make and should be made
as the last resort and only after prolonged, careful study.
The choioe of an analgesic agent must depend on several other
factors. The severity of the pain requires careful consideration.
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Regardless of the etiological factor, it is convenient to suibdivide the
severity into very severe, moderately severe, and mildly severe. As
pointed out previously, this is dependent entirely upon the patient's
own admission, but it must be templered by the appearance of the
patient, including the general physical and associated symptoms.
The duration and the constancy of the pain decidedly influence the
choice and evaluation of an analgesic. If the pain is constant, such
as is seen with malignancies or surgical conditions, a short acting or
rapidly dissipating drug may not show up to advantage in spite of
the fact that complete analgesia is obtained for one to hours. Upon
recurrence of the pain, the patient invariably will report that the
analgesic was not effective. It is too much to expect the patient to
appreciate the fact that the medication does not eradicate the disease
but only alleviates a symptom.
The physician should also be aware that potent analgesic drugs,
probably on the basis of unpredictable untoward reactions, do not
lend themselves readily to the treatment of ambulatory patients.
It is truethatthe majority of such patients do not possess severe pain,
but we are definitely restricted in -the use of analgesics becausie the
mild preparations available at the present time are not very effective
and the potent preparations may produce unpleasant side reactions
which not only require caution in their use, but also depreciate their
usefulness. The best example of this is the use of demerol in
ambulatory patients.' Side reactions are very common and may
occur in 70 per cent of the patients, while the incidence for the same
dose and route of administration for hospitalized and recumbent
patients is no higher than 27 per cent. All analgesic agents have
a higher incidence of untoward reactions for ambulatory patients,
but because they are not too serious they are often overlooked and are
not regarded as significant. This brings up the necessity of studying
all new analgesic agents in ambulatory as well as in hospitalized
patients. Sometimes unusual reactilons not encountered in bedridden
patients become evident. Recently, we had the opportunity to study
a new analgesic drug, a trimethyloxazolidine derivative which had
the clinical potency of codeine. Hospitalized patients could tolerate
tremendous doses, both intravenously and orally with little if any
toxicity. When the drug was given to ambulatory patients, how-
ever, practically all returned with the similar story of marked visual
disturbances. In several instances, the patient had consulted an
optometrist because the refractory index was changed. Every
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patient, however, fortunately had restoration of normal vision upon
discontinuance of the drug.
The preceding discussion has indicated in general the various
factors that are considered in clinically evaluating new analgesic
drugs. To be more explicit, the drug is considered for clinical use
when the pha'rmacological data in laboratory animals indicate its
toxicity, its cardiovascular and respiratory actions, as well as its
ability to raise the pain threshold. The drug is then administered
to both hospitalized and ambulatory patients with every type and
severity of pain. For the hospitalized patient, the parentetral route
of administration is preferable since, if the drug has an analgesic
action, its effect will be noted promptly, and usually within 15
minutes. At first, very little attention is paid to the possibility of
analgesia, since nothing is known about the effective dose. Emphasis
is upon untoward reactions, and on cardiovascular and respiratory
actions. When the minimal effective safe dose is determined the
drug is used freely in place of the accepted analgesics. The effec-
tiveness of the analgesic is then analyzed accordingto four categories.
(1) Complete control of pain, including complete relief of pain for
three or more hours and al;most complete relief of pain for several
hours. In this group untoward reactions are minimal or entirely
absent. (2) Moderate control of pain, including complete relief
and almost complete relief of pain for under three hours, partial
relief for three hours or more and relief as described in the first
category if untoward reactions are disturbing and do not permit
complete comfort. (3) Slight control of pain, including partial
relief for under three hours and relief as described in the first and
second categories if untoward reactions are moderately severe. (4)
No control of pain, including failure to affect pain and relief as
described in the first 3 categories if untoward reactions are severe.
In our experience, an effective analgesic, regardless of its ultimate
potency, should give, by the parenteral route, satisfactory control of
pain in over 60 per cent of the trials and if given orally in between
40 and 60 per cent. If the drug possesses specificity for a particular
disease or function, then the incidence should approach 80 to 90
per cent.
We can thus set forth the following criteria for effective and
suitable analgesic agents.
(1) The drug should be reliable in producing satisfactory anal-
gesia, regardless of the underlying pathological disease. Analgesics
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for severe pain should be capable of producing satisfactory control
when administered parenterally in 90 to 95 per cent of the trials,
and in 60 to 70 per cent when administered orally.
(2) Since a large number of patients have severe pain on the
basis of spasm of smooth muscle, it would be an advantage to have
a drug with analgesic and antispasmodic actions. At least the drug
should not result in further spasm of smooth muscle throughout the
body; an action which in some instances may be detrimental to the
patient's welfare.
(3) The drug should have little or no untoward reactions, par-
ticularly upon the carditovascular and resipiratory systems.
(4) When administered orally to ambulatory patients, the drug
should be capable of allevialting moderate degrees of pain for several
hours without an increased incidence of side reactions.
(5) A somnifacient or sedative action should be minimal or non-
existent.
(6) Prolonged use of thie drug should not result in cumulation.
(7) Repeated administration should be free of tolerance, so that
the same analgesic effect will always be expected with the same dose.
(8) The drug should not lead to addiction. We are more con-
cerned with the development of physical dependence than psychic
addiction, since it is unlikely that any potent drug possessing a bene-
ficial action of analgesia would be free of the latter stigmata.
(9) The drug must be safe to be administered to patients of all
ages and in all diseases without fear of contraindication or potentia-
tion of an untoward response.
(10) Finally, there are some minor considerations, such as ease
of administering the drug, irritation upon injection or ingestion,
deterioration on storage, and so forth.
In the light of these criteria let us consider a new synthetic
analgesic introduced in 1943 by Dodds, Lawson, and Williams.3
These investigators pointed out the chemical relationship of diphen-
ylethylamine to morphine and presented pharmacological and pre-
liminary clinical data indicative of the analgesic action of this group
ofcompounds. The most promising was the beta-hydroxy alpha beta
diphenylethylolamine. Our studies consisted in administering both
the "normal" as well as the "iso" form of this compound to a group
of 104 patients presenting a wide variety of painful conditions. The
study was carried out with three groups of patients for each prepa-
ration. Hospitalized patients were treated both orally and paren-
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terally, while ambulatory patients were given only the oral prepara-
tion. With doses from 50 to 200 mg. (average 100 mg.) every 4
hours we were able to demonstrate an analgesic action of only 54
per cent effectiveness for either preparation and by all routes. The
drug was, therefore, not very reliable in producing analgesia. This
is particularly so for the parenteral route which would ordinarily be
used for severe pain. Side reactions for the hospitalized patients
were of minor significance and took the form of an occasional occur-
rence ofnausea, vomiting, anddizziness. Ambulatory patients, how-
ever, presented in addition to these, faintness, headache, aniorexia,
perspiration, and constipation. Since these occurred with a dose
which gave only slight analgesia or none at all, it was very difficult
in this group of patients to obtain the proper therapeutic dose. For
the hiospitalized patients, however, the oral preparation appeared to
be satisfactory for the mild to moderate types of pain. The ques-
tions of tolerance, accumulation, and addiction remain unanswered,
since the analgesic potency of this compound precluded further
investigation with it.
No discussion of analgesia would be complete without a brief
consideration of morphine. This drug has been generally accepted
as the standard for analgesics, since, without question; it is the most
patent of all. By any means of study, whether by pain threshold
measurements or by actual clinical trial, it is supreme for analgesia.
Regardless of the severity of the pain or the responsible underlying
pathological process, an appropriate dose given subcutaneously will
result in relief of pain in over 90 per cent of the patients so treated.
Duration of analgesia is primarily dependent upon the severity of
the pain, but is usually 3 hours. In the vast majority of patients
this is as long as one would wanit an analgesic to be active. A more
prolonged action would materially interfere with and depreciate a
valuable clinical sign of the patient's progress, namely, the persistence
ofthe pain. However, in manypatients, such asthose with advanced
malignancies, where this is not a factor, a drug producing relief of
pain for no longer than 3 hours may be considered to be unsatis-
factory. This is particularly so if repetition of the drug at 3-hour
or even 4-hour intervals may result in cumulation of untoward
reactions such as profound narcosis or respiratory depression. These
reactions will be considered in a moment, but we cannot escape the
fact that this drug admirably meets the first of our criteria for an
effective and suitable analgesic agent. However, upon further
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analysis it is at once apparent that the drug possesses many serious
disadvantages which definitely impair its usefulness. First of all,
a therapeutic dose always results in a spasmogenic action upon the
smooth muscle of the gastro-intestinal, biliary, genito-urinary, and
respiratory tracts. Thus, a patient with colicky pain arising from
any smooth muscle origin not only has an increase in muscle spasm
but this in turn may also increase the pain temporarily until the
central analgesic action becomes evident. To counteract this action,
atropine (or its derivatives) is usually administered simultaneously.
Why should it be necessary to use another drug to offset an unques-
tionably undesirable action of an analgesic?
Upon the gastro-intestinal tract the drug in addition invariably
produces a generalized increase in tone and spasm of the sphincters
which delays the normal emptying time of the stomach and possibly
interferes with normal digestive functions and also results in consti-
pation. This is a desirable action for the treatment of diarrhea, but
why should a patient receiving relief of pain be made uncomfortable
with constipation, especially since the constipation is not easily recti-
fiied by the usual medication when the analgesic is administered over
a prolonged period? Granted that in most patients this is of minor
consequence, in postoperative patients it maydefinitely interfere with
the proper management of bowel function and probably contribute
topostoperative distension and ileus.
Spasm of thetrigone muscle of the urinary bladder with urinary
retention is not uncommon. This action in postoperative patients
may result in serious consequences necessitating frequent catheteriza-
tions and possible development of ascending genito-urinary infec-
tions. Elderly males with hypertrophied prostates, in particular,
must be observed very carefully if one wishes to avoid uremia.
Spasm of the bronchial musculature in the majority of patients
is of no consequence, but may be dangerous if the patient has bron-
chial asthma. Numerous examples of the seriousness of this action
and the possibility of 'the patient's sudden death can be found in
the literature.6
Untoward reactions other than smooth muscle spasm are very
common. The most important is depression of respiration. All
patients to some degree present this action, but it is serious in only
a few. Since it occurs readily in patients with cerebral arterioscle-
rosis, marked de-bilitation, anemias, and intercranial diseases, such
as brain tumors, and in skull fractures, morphine must be used with
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caution or not at all in these cases. Although it may not occur with
the initial dose, it may if doses are repeated every 4 hours or
oftener. This definitely impairs its usefulness in patients with
chronic pain, because as the effects of analgesia subside in 3 hours
the respiratory effects are more prolonged and readily cumulate with
repeated doses. This is offset bythe rapid developmen(t of tolerance
to respiratory depression, but, nevertheless, the patient must be
watched very carefully during this phase of therapy. Its use for
obstetrical analgesia may result in severe fetal respiratory depression.
Morphine cannot be administered to all patients with equal
safety. In addition to those patients already mentioned, we have
the marked sensitivity of infants and the increased reactivity of the
aged. Furthermore, it must be used with caution in patients with
liver disease and with hypothyroidism. Nausea and vomiting are
very frequent. The occurrence of intense pruritus and urticaria may
be very disturbing.
Pupillary constrictions may interfere with the proper manage-
ment of neurological patients and with the valuable pupillary signs
which are followed during general anesthesia.
Depression of the cough reflex may be of value for the treatment
of this distressing symptom, but in postoperative patients it interferes
with adequate drainage of the respiratory tract and may contribute
to the development of postoperative pneumonitis and atelectasis.
Because of this action, its use is restricted in patients with chronic
lung disease, since it may result in extension of the pathological
process.
It is generally accepted that the production of sleep is not a
necessary component of analgesia. Yet morphine invariably will
produce a somnifacient action which in sensitive patients may develop
into a deep narcosis. Unfortunately, this is another action which is
cumulated on early repetitive doses. Occasionally the converse
action occurs with the patient experiencing marked excitement,
delirium, or psychosis.
Adequate statistics on the incidence of side reactions in ambula-
tory patients are not available, mainly because the use of morphine
is reserved for severe pain of hospitalized patients. However, in
a few ambulatorypatients treated the occurrence of dizziness, nausea,
vomiting, and weakness definitely impaired the usefulness of the
drug.
Patients with chronic pain demand a drug which will not only
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be effective but will also continue to give the same analgesic effect
with the samedose when administered repeatedly. It is well known
that this is impossible with morphine. Usually after 2.or 3 weeks
of continuous therapy, it will be necessary to increase the dose to
achieve the same analgesic action. A point is eventually reached
where further tolerance to analgesia no longer occurs and the patient
will continue to have relief of pain with a constant but increased
dose. Unfortunately, when this stage is reached the patient has
cumulated many effects which upon withdrawal of the drug are
manifested as addiction symptoms or abstinence phenomena.
Although there may be considerable controversy about what is
actually meant by addiction, it isdifficult to ignore the fact that prac-
tically every patient receiving morphine or its derivatives at closely
repeated intervals for long periods of time will manifest, upon ces-
sation of the drug, some withdrawal symptoms. These patients
may not be aware of their dependence and do not manifest the
personality changes which are commonly associated with the accepted
conception of an addict. Nevertheless, they have developed a
physical dependence to the drug which definitely handicaps their
future treatment.
This review of morphine in terms of meeting our criteria for a
good analgesic is indicative of only one thing. Although morphine
meets our first requirement for a potent, efficacious analgesic, it
possesses many adverse pharmacological actions that seriously out-
weigh its therapeutic advantages. We must conclude from the
evidence available that morphine and its potent derivatives are not
entirely safe drugs. Ever since Serturner in 1803 discovered and
isolated morphine from opium the medical profession has accepted
its virtues without too much concern over its potentialities to do
harm. The pharmacologist and chemist, however, have recognized
these disadvantages of morphine. This is well reflected in the hun-
dreds ofmorphinederivatives that have been synthesized in an effort
to alter or remove some detrimental action. Before leaving the
subbject of morphine, I would like to raise this question: If we may
assume that morphine was not in existence and that it is being intro-
duced today as a new drug with analgesic potentialities, in light of
our present knowledge would it be acceptaible to the Food and Drug
Administration and released as a safe drug without provisions for
adequfate warning as to its dangers?
It is obvious that none of the drugs available today meet all of
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the requirements demanded for a suitable and effective analgesic
agent. Actually, the majority fall far short of our criteria. Thus,
there is room for much more work and for the development ofdrugs
which may be of value for clinical analgesia.
Inconclusion I wish to stress the importance ofthe clinical evalu-
ation of analgesic drugs and emphasize the importance of considering
the symptom of pain only in relation to the patient as a whole.
Unless this is done, we fail in the main objective of these drugs,
namely, the temporary symptomatic relief ofthe condition while the
cause is searched for and eradicated.
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